Combined oral contraceptive use before the first birth and epithelial ovarian cancer risk

BACKGROUND: Combined oral contraceptive (COC) use reduces epithelial ovarian cancer (EOC) risk. However, little is known about risk with COC use before the first full-term pregnancy (FFTP). METHODS: This Canadian population-based case–control study (2001–2012) included 854 invasive cases/2139 contro...

Descripción completa

Detalles Bibliográficos
Autores principales: Cook, Linda S, Pestak, Claire R, Leung, Andy CY, Steed, Helen, Nation, Jill, Swenerton, Kenneth, Gallagher, Richard, Magliocco, Anthony, Köbel, Martin, Brooks-Wilson, Angela, Le, Nhu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5243988/
https://www.ncbi.nlm.nih.gov/pubmed/27959890
http://dx.doi.org/10.1038/bjc.2016.400

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5243988/
https://www.ncbi.nlm.nih.gov/pubmed/27959890
http://dx.doi.org/10.1038/bjc.2016.400

Ejemplares similares